Genomic Medicine and Cancer

Genomic Medicine and CancerFor the nurse navigator professional, continuing education is a critical component for maintaining certain state and certification requirements. Through up-to-date with education and treatment knowledge, navigators also have the opportunity to properly inform patients and provide culturally targeted information to their families – ultimately helping to create comprehensive and seamless care. Staying on top of current cancer news and research, genomic medicine and cancer, for example, is critical part of the nurse-patient communication process.

How Education Impacts Patient Outcomes

In a recent article, A Day in the Life of a Nurse Navigator: Education That Changes Lives, the author touches on the importance of staying in-the-know and how the education given by nurse navigators can have significant impacts on patient outcomes:

“As nurse navigators, we fall into the same boat as these teachers of young minds. Information we give to a patient today can be like a small seed landing in the fertile mind of that patient. That seed of information may take us a couple of minutes to deliver, and we need to be intent on educating while we do it, but when done well, it can be life changing. We may not know today, or even in the next few days or months, how this information has impacted the life of our patient, but we know, without a doubt, that educating a patient well does change lives.”

It’s apparent that nurse navigators play an important role in educating patients by raising awareness about the latest in research and treatment. One prime topic in the news today that all nurse navigators should be up to speed with is genomic medicine and cancer care.

Research and Treatment News: Genomic Medicine and Cancer

There’s no question that understanding a patient’s extent of risk is critical to quality patient care. And as genomic medicine continues to influence research and treatment options, that understanding becomes even more paramount.

Genomic medicine involves utilizing genomic information about a patient as part of their clinical care by revealing abnormalities in genes that drive the development and growth of many types of cancer. This results in earlier detection of genetic predisposition to cancer and has been shown to improve the diagnosis and prediction of treatment efficacy. Over the past decade, research has surveyed and cataloged the genomic changes associated with several types of cancer. These efforts have revealed unexpected genetic similarities across different types of tumors.

According to, “The wealth of data emerging from cancer genome studies increasingly will be integrated with patients’ medical histories and clinical data. These integrated results could be used to develop more tailored approaches to cancer diagnosis and treatment, as well as to improve methods of predicting cancer risk, prognosis, and response to treatment.”

As the next frontier in cancer care, nurse navigators should consider integrating education about hereditary testing as part of their clinical workflow.

Your Patients Rely On You. You Can Rely On Us.

To be able to provide such education to patients, it’s imperative to know where everything is going in terms of research and treatment. At OncoNav, our support team is comprised of nurse navigators and oncology professionals with decades of experience in the industry and who are aware of and familiar with the latest oncology research.

Find out how OncoNav can be a beneficial and valuable resource for your facility today schedule your free demonstration today. We offer on-call customer support service Monday through Friday from 8 a.m. to 7 p.m. ET at (888) 369-1791 or by email at